Ticagrelor, but not clopidogrel, attenuated hepatic steatosis in a model of non-alcoholic fatty liver disease

被引:0
|
作者
Oh, Hyunwoo [1 ]
Lee, Hyo Young [1 ]
Park, Huiyul [2 ]
Jun, Dae Won [3 ]
Yoon, Eileen [3 ]
Ahn, Sang Bong [4 ]
Lee, Chul-min [5 ]
Kim, Mi Mi [5 ]
Kang, Bo-Kyeong [5 ]
Sohn, Joo Hyun [6 ]
机构
[1] Uijeongbu Eulji Med Ctr, Dept Med, Uijeongbu Si, Gyeonggi do, South Korea
[2] Uijeongbu Eulji Med Ctr, Dept Family med, Uijeongbu Si, Gyeonggi do, South Korea
[3] Hanyang Univ, Coll Med, Dept Med, Seoul, South Korea
[4] Eulji Univ, Nowon Eulji Med Ctr, Sch Med, Dept Med, Seoul, South Korea
[5] Hanyang Univ, Coll Med, Dept Radiol, Seoul, South Korea
[6] Hanyang Univ, Guri Hosp, Coll Med, Dept Med, Ansan, Gyeonggi do, South Korea
关键词
D O I
暂无
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
SAT135
引用
收藏
页码:S728 / S729
页数:2
相关论文
共 50 条
  • [1] Assessment of hepatic steatosis algorithms in non-alcoholic fatty liver disease
    Eremic-Kojic, N.
    Deric, M.
    Govorcin, M. L.
    Balac, D.
    Kresoja, M.
    Kojic-Damjanov, S.
    HIPPOKRATIA, 2018, 22 (01) : 10 - 16
  • [2] Assessment of hepatic steatosis algorithms in non-alcoholic fatty liver disease
    Kojic, N. Eremic
    CLINICA CHIMICA ACTA, 2019, 493 : S362 - S362
  • [3] Decreased Hepatic Lactotransferrin Induces Hepatic Steatosis in Chronic Non-Alcoholic Fatty Liver Disease Model
    Lee, Sungmin
    Son, Beomseok
    Jeon, Jaewan
    Park, Gaeul
    Kim, Hyunwoo
    Kang, Hyunkoo
    Youn, HyeSook
    Jo, Sunmi
    Song, Jie-Young
    Youn, BuHyun
    CELLULAR PHYSIOLOGY AND BIOCHEMISTRY, 2018, 47 (06) : 2233 - 2249
  • [4] Pathogenesis of hepatic steatosis:The link between hypercortisolism and non-alcoholic fatty liver disease
    Giovanni Tarantino
    Carmine Finelli
    World Journal of Gastroenterology, 2013, (40) : 6735 - 6743
  • [5] Role of exercise in the mechanisms ameliorating hepatic steatosis in non-alcoholic fatty liver disease
    Russell-Guzmán J.A.
    Karachon L.
    Gacitúa T.A.
    Freundlich A.
    Poblete-Aro C.E.
    Rodrigo R.
    Sport Sciences for Health, 2018, 14 (3) : 463 - 473
  • [6] Continuum of non-alcoholic fatty liver disease: from hepatic steatosis to cardiovascular risk
    Drapkina, O. M.
    Korneeva, O. N.
    RATIONAL PHARMACOTHERAPY IN CARDIOLOGY, 2016, 12 (04) : 424 - 429
  • [7] Pathogenesis of hepatic steatosis: The link between hypercortisolism and non-alcoholic fatty liver disease
    Tarantino, Giovanni
    Finelli, Carmine
    WORLD JOURNAL OF GASTROENTEROLOGY, 2013, 19 (40) : 6735 - 6743
  • [8] Adipokines and Endotoxemia Correlate with Hepatic Steatosis in Non-Alcoholic Fatty Liver Disease (NAFLD)
    Nier, Anika
    Huber, Yvonne
    Labenz, Christian
    Michel, Maurice
    Bergheim, Ina
    Schattenberg, Joern M.
    NUTRIENTS, 2020, 12 (03)
  • [9] Non-alcoholic fatty liver disease: from steatosis to cirrhosis
    Leclercq, Isabelle
    Sempoux, Christine
    ACTA ENDOSCOPICA, 2006, 36 (03) : 299 - 314
  • [10] Hepatic ceramides dissociate steatosis and insulin resistance in patients with non-alcoholic fatty liver disease
    Luukkonen, Panu K.
    Zhou, You
    Sadevirta, Sanja
    Leivonen, Marja
    Arola, Johanna
    Oresic, Matej
    Hyotylainen, Tuulia
    Yki-Jarvinen, Hannele
    JOURNAL OF HEPATOLOGY, 2016, 64 (05) : 1167 - 1175